New conversation tool aims to improve End-of-Life care for kidney patients
NCT ID NCT04466865
First seen Oct 31, 2025 · Last updated Jun 23, 2026 · Updated 31 times
Summary
This study tested a communication tool called 'Best Case/Worst Case' for older adults with advanced kidney disease. Doctors were trained to discuss best, worst, and most likely outcomes for treatment options. The goal was to see if this approach helps patients receive more palliative care and make decisions that match their preferences. Over 400 patients from ten clinics took part, with follow-up for up to two years.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for END STAGE RENAL DISEASE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Columbia University
New York, New York, 10027, United States
-
Department of Medicine, University of Vermont
Burlington, Vermont, 05405, United States
-
Johns Hopkins University
Baltimore, Maryland, 21287, United States
-
Medical College of Wisconsin
Milwaukee, Wisconsin, 53226, United States
-
Mount Sinai School of Medicine
New York, New York, 10029, United States
-
Northwestern University
Chicago, Illinois, 60611, United States
-
University of Colorado, Denver
Denver, Colorado, 173364, United States
-
University of Michigan
Ann Arbor, Michigan, 48105, United States
-
University of Pittsburgh
Pittsburgh, Pennsylvania, 15260, United States
-
University of Washington
Seattle, Washington, 98195, United States
-
West Virginia University
Morgantown, West Virginia, 26506, United States
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Best Case/Worst Case communication tool training
What this could lead to
If this works, it could help doctors and patients have better conversations about treatment choices and end-of-life care, leading to more personalized care plans.
What could go wrong
This is a completed study testing a communication method, not a drug or cure. The tool may not change actual care or outcomes, and results may not apply to all settings.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.